VIM and Alzheimer disease: For example, the intermediate filament protein vimentin, which co-localizes with Aβ in the cerebral cortex, cerebellum and hippocampus of AD brains (Levin et al., 2009), was increased in N2a/APP vs. N2a/WT cells and suppressed in N2a/APP cells treated with Xn (0.19 and 0.75 μM).